Why are osteoporosis patients treated with antiresorptive therapies considered like oncology patients regarding their oral health care?

Cordova, Luis A; González-Quintanilla, David; Heymann, Dominique

Cordova, Luis A; González-Quintanilla, David; Heymann, Dominique.

Afiliación

Cordova LA; Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, University of Chile, Sergio Livingstone Polhammer 943, Independencia, Santiago, Chile. luis.cordova@unab.cl.
González-Quintanilla D; Craniofacial Research Lab, Faculty of Dentistry, Universidad Andres Bello Santiago, Echaurren 272, Santiago, Chile. luis.cordova@unab.cl.
Heymann D; IMPACT, Center of Interventional Medicine for Precision and Advanced Cellular Therapy, Av. Mons. Álvaro del Portillo 12455, Las Condes, Santiago, Chile. luis.cordova@unab.cl.

Osteoporos Int ; 2024 Jun 27.

Article en En | MEDLINE | ID: mdl-38935084

Palabras clave

Antiresorptive; Osteonecrosis of the jaw; Osteoporosis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Idioma: En Revista: Osteoporos Int Asunto de la revista: METABOLISMO / ORTOPEDIA Año: 2024 Tipo del documento: Article País de afiliación: Chile

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google